Apollo Medical Optics, Ltd. develops and manufactures medical imaging devices for healthcare applications, focusing on cellular level resolution images.

Apollo Medical Optics, Ltd.

See to Cure.

Apollo Medical Optics (AMO) develops optical coherence tomography imaging devices.  With the unique light source originated from National Taiwan University, the in vivo cellular imaging system provides clinicians a non-invasive tool to capture three-dimensional cellular resolution images.  Our system targets to allow clinicians to reduce the numbers and frequency of skin biopsies.

contact@mdamo.com    
(+886) 2-8752-3198

🌞See you next week in Singapore! 
From 9/11 to 9/13, we’ll be at the 2024 Medical Fair Asia, and we’re excited to bring our latest innovation, SeeKIN! 🚀

This advanced skin layer optical scanning device tracks and monitors skin disease and aesthetic treatments like never before. 

Here's what it offers:
✨ AI-powered reports
✨ Detection of melanosomes, active melanocytes, and collagen fibers
✨ Horizontal and vertical imaging to explore cellular structures under the skin

🎇 SeeKIN is the best partner for dermatologists.
😎 Come check us out at booth 2U23!

#MFA #Singapore #exhibition #SeeKIN #2U23 #medical #AMO

【 🙌 Congratulations! AMO has another melasma paper published!】

👨⚕️ How can we accurately treat melasma? Melasma is a complex pigmentary disorder caused by a combination of factors, including genetics, hormones, and UV exposure.

In the past, studies have shown that the presence of activated melanocytes in melasma lesions can be related to relapse of melasma and other side effects after treatment.  Therefore, the skin condition should be examined at a cellular level to reveal the activated melanocytes prior to treatment. 

In our current study, AMO's CRFF-OCT combined with AI successfully demonstrated the observation and quantification of activated melanocyte at the basal layer, this critical information allows dermatologists to better determine treatment strategy.  In this study, various photoaging characteristics widespread in the skin of melasma patients were also observed. These include basement membrane damage and increased number of blood vessels. 

Overall, these cellular features cannot be seen with naked eyes. AMO's CRFF-OCT allows physicians to utilize these information to guide melasma treatment, realize precision medicine, and reduce side effects!

✨ The research study entitled “Photoaging features of melasma: An in vivo layered and quantitative analysis using computer-aided detection of cellular resolution full-filed optical coherence tomography” was published on JEADV.

😊 Thank you to all the dermatologists for your unwavering support of AMO.

#AMO #CRFFOCT #AI #photoaging #melasma #melanocytes #melanin #personalized medicine #Precision treatment

【 📢 Breaking News: FF-OCT Revolutionizes Vitiligo Treatment! 】
 󠀠
👀 How long does it take to determine the success of skin grafting treatment for vitiligo? Or is there a way to detect signs of improvement before the skin regains color?
 󠀠
🙌 Look no further! AMO's groundbreaking innovation, a high-cellular-resolution full-field optical coherence tomography (CRFF-OCT) coupled with artificial intelligence (AI), offers a game-changing non-invasive method to monitor vitiligo lesions post-tissue grafting.
 󠀠
Recent studies spanning over six months have unveiled CRFF-OCT's remarkable capabilities. It can pinpoint initial indications of melanocyte recovery in the skin, and AI-quantified melanin and dendritic cells in CRFF-OCT images can be identified before visible color restoration occurs. This cutting-edge advancement instills confidence in both patients and dermatologists in treating vitiligo. 💪 
 󠀠
🧐 Join the revolution in vitiligo treatment with AMO's pioneering technology!
 󠀠 #vitiligo  #innovation #treatment  #dermatology  #AMO #healthcare 

Please see the publication 👇 :
https://lnkd.in/gxmHhCW5
 
Citation: Lu, L.-Y.; Chen, Y.-T.; Chen, I.-L.; Shih, Y.-C.; Liu, R.T.-L.; Lai, Y.-J.; Ng, C.Y. Feasibility of High-Cellular-Resolution Full-Field, Artificial-Intelligence-Assisted, Real-Time Optical Coherence Tomography in the Evaluation of Vitiligo: A Prospective Longitudinal Follow-Up Study. Bioengineering 2024, 11, 196.

🐲 Wish you good luck in the year of the dragon.

🎇 Happy New Year!

🎄 Merry Christmas！
󠀠
✨ Sending our warmest wishes for a wonderful holiday season full of joy and happiness.

🎉 【Unlocking the Future of Dermatology: ApolloVue® S100 at the CDA Exhibition in China!】
󠀠
🎇 The AMO booth stole the spotlight at the 2023 CDA exhibition in China as doctors flocked to witness something truly extraordinary. Imagine skin images presented in both vertical and horizontal sections, akin to a Rubik's Cube effortlessly rotating for a comprehensive view. What incredible instrument makes this magic happen?
󠀠
They are introducing the ApolloVue® S100 (FF-OCT), a game-changer in dermatology! This innovative device seamlessly blends skin images, constructing a mesmerizing 3D representation. Doctors can manipulate and explore every angle, turning it into the ultimate tool for dermatologists.
󠀠
But that's not all – the ApolloVue® S100 (FF-OCT) isn't just transforming the clinical landscape; it's shaping the future of dermatology education in China. Integrated into professional online courses, it empowers dermatologists to grasp both vertical histopathology and horizontal images. This reshapes the learning curve, propelling dermatologists forward with unprecedented speed and precision.
󠀠
💪 AMO aims to accelerate progress, aiding clinical professionals in serving patients more efficiently. As we eagerly anticipate future developments, we aspire to collaborate with even more clinical dermatologists, collectively advancing the dynamic field of dermatology.
󠀠
🙌 Join us on this transformative journey as we redefine the possibilities in dermatological care. The future is now, and AMO is at the forefront, pioneering advancements that echo across the entire realm of dermatology!
󠀠
#FFOCT #AMO #dermatology  #CDA #3D #image

🌕 A bright moon and stars twinkle and shine. Wishing you a merry Mid-Autumn Festival, bliss, and happiness.

🛫 AMO's Journey at PCHi: Unveiling the Future of Skincare
 
🎇 Skincare has taken the spotlight like never before in an exciting year filled with exhibitions. Last month, AMO took center stage at the prestigious China International Personal Care and Homecare Ingredients (PCHi) event, cosmetic formulators, manufacturers, and R&D experts from across the globe. Our presence at PCHi reaffirmed the groundbreaking potential of the "FF-OCT Cellular Skin Perspective System" in the world of skincare management.
 
💪 The "FF-OCT Cellular Skin Perspective System" is a game-changer. It goes beyond the surface, offering a deep dive into skin health. From skin thickness to spot melanin and collagen fibers, this technology provides precise insights, enabling tailored skincare for everyone. This concept is redefining beauty standards and has earned accolades from industry professionals.
 
Our journey at PCHi was nothing short of enlightening. We're immensely grateful to all the friends and partners who stopped by our booth. Your support and enthusiasm were truly inspiring.
 
🙋♂️ As we look ahead, AMO is committed to delivering more surprises and innovations in the skincare world. Stay tuned for the latest developments as we continue our mission to redefine beauty through technology.
 
🙌 We extend our heartfelt thanks to our supporters and collaborators. Your trust in AMO drives us to push boundaries and pioneer new horizons in skincare.
 
#SkincareRevolution
#PCHi2023
#FFOCT
#ApolloMedicalOptics

APOL

COM:APOLLOMEDICALOPTICS

Apollo Medical Optics, Ltd.

Analysis Not Available